ArticleInternational journal of epidemiology2025
Coronary heart disease and stroke mortality trends in Australia and New Zealand: comparison of official national mortality data and Global Burden of Disease estimates.
Article in International journal of epidemiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- The impact of temporal trends in stroke event rates and 30-day case fatality on trends in stroke mortality: an international comparative study.International journal of epidemiology · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundRecent Global Burden of Disease (GBD) estimates show increasing cardiovascular disease (CVD) mortality in Australia and New Zealand, prompting concern. This study investigates whether such increases are observed in official national data.
methodsAnnual age-standardized coronary heart disease (CHD) and stroke mortality rates for ages 35-84 years in Australia/New Zealand from 2008 to 2018/19 were calculated using official national data and published GBD estimates. Differences in annual mortality rate percentage changes between official data and GBD estimates were calculated separately for each country. Joinpoint regression identified temporal trend changes.
resultsOfficial data showed annual decreases in CHD mortality of 4.9% (95% CI: 4.4%-5.5%) for Australia and 4.2% (3.7%-4.7%) for New Zealand on average; corresponding annual stroke mortality reductions were 4.3% (3.2%-5.3%) for Australia and 3.7% (2.9%-4.5%) for New Zealand. Absolute CHD mortality rates from GBD were substantively higher than from official data (e.g. 104.7 [103.0-106.5] vs 99.0 [97.3-100.7] per 100 000 people, respectively, Australia, 2008). Contrasting with ongoing declining rates using official data, GBD estimates showed slower overall mortality rate declines, recent increases in CHD mortality (e.g. 1.2% [0.2%-2.2%] annual increases from 2016 to 2019 for Australia), and stagnating stroke mortality. Differences are likely explained by GBD's redistribution of ill-defined causes of death and use of projected data after 2016, when national mortality data were unavailable for GBD estimates.
conclusionsCHD and stroke mortality in Australia/New Zealand continue to decline, according to gold-standard official data. Disparities with GBD estimates highlight the need for transparency in reporting GBD methods and care in interpretation and application.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.